NIH-funded research Fellowship grant

Understanding how immune cells affect ALS progression

Official title: The Role of Neutrophil Heterogeneity and Molecular Mechanisms in Driving ALS

Funded at University of Michigan at Ann Arbor · NIH-10997602 · Data updated 2026-11-12

This study is looking at how a type of immune cell called neutrophils might affect the progression of ALS by examining blood samples from patients, with the hope of finding new ways to help manage the disease.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$43,051
NIH project number1F31NS139629-01
Project IDNIH-10997602 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis (ALS).

Less likely to help

Patients with other neurological conditions unrelated to ALS may not benefit from this research.

What this research studies

This research investigates the role of neutrophils, a type of immune cell, in the progression of amyotrophic lateral sclerosis (ALS). It aims to understand how these cells respond to neuronal damage and whether they contribute to the worsening of the disease. By analyzing blood samples from ALS patients, the study will explore the relationship between neutrophil levels and disease progression, potentially identifying new therapeutic targets. The research combines laboratory analysis with predictive modeling to assess the impact of neutrophils on motor neuron health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or alter the progression of ALS.

How similar studies have gone: Previous studies have shown that immune responses play a significant role in ALS, suggesting that this research could build on established findings.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Baird, Lillia — University of Michigan at Ann Arbor
  • Study coordinator: Baird, Lillia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.